Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: a case series

Overview of attention for article published in Journal of Medical Case Reports, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,803 followers.

New article: Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: a case series https://t.co/LWFBGITjf5 #melanoma #oncology https://t.co/ganwf9BihF

Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: a case series https://t.co/h2s2VV9gMx

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.